Characterization of Venezuelan patients with systemic sclerosis: a study in a tertiary hospital in Caracas

Denton, 2017, Systemic sclerosis, Lancet, 390, 1685, 10.1016/S0140-6736(17)30933-9 Schoenfeld, 2015, Interstitial lung disease in scleroderma, Rheum Dis Clin North Am, 41, 237, 10.1016/j.rdc.2014.12.005 Shanmugam, 2012, Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenes is and management, Curr Opin Rheumatol, 24, 669, 10.1097/BOR.0b013e3283588dcf Bergamasco, 2019, Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease, Clin Epidemiol, 11, 257, 10.2147/CLEP.S191418 Alarcón, 2015, Contribution of ethnic group and socioeconomic status to degree of disability in rheumatoid arthritis in Chilean patients, Rheumatol Int, 35, 685, 10.1007/s00296-014-3123-y Gelber, 2013, Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of literature, Medicine (Baltimore), 92, 191, 10.1097/MD.0b013e31829be125 Rosa, 2011, Incidence and prevalence of systemic sclerosis in a healthcare plan in Buenos Aires, J Clin Rheumatol, 17, 59, 10.1097/RHU.0b013e31820e7e8d Quintana, 2016, Prevalence of musculoskeletal disorders and rheumatic diseases in the indigenous Qom population of Rosario, Argentina, Clin Rheumatol, 35, 5, 10.1007/s10067-016-3192-2 Gottshalck, 2014, Scleroderma in the Caribbean: characteristics in a Dominican case series, Reumatol Clin, 10, 373, 10.1016/j.reuma.2014.01.011 Rodriguez-Reyna, 2011, Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients, Autoimmunity, 44, 576, 10.3109/08916934.2011.592886 Scolnik, 2014, Systemic sclerosis in Argentina: evaluation of a large cohort from a single centre and comparison with other international series, Clin Exp Rheumatol, 32, S94 Granados, 2016, Prevalence of musculoskeletal disorders and rheumatic disease in the Warao, Kari’ña, and Chaima indigenous populations of Monagas State, Clin Rheumatol, 35, S53, 10.1007/s10067-016-3194-0 Bauce, 2010, Cuestionario socioeconómico aplicado a grupos familiares del Distrito Capital para investigaciones relacionadas con la salud pública, INHRR, 41, 14 Khanna, 2017, Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis, J Scleroderma Relat Disord, 2, 11, 10.5301/jsrd.5000231 LeRoy, 1988, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J Rheumatol, 15, 202 Khanna, 2013, Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension, Arthritis Rheum, 65, 3194, 10.1002/art.38172 Morgan, 2017, Clinical and serological features of systemic sclerosis in a multicenter African American cohort: analysis of the genome research in African American scleroderma patients clinical database, Medicine (Baltimore), 96, e9880, 10.1097/MD.0000000000008980 Walker, 2007, Clinical risk assessment of organ manifestations in Systemic Sclerosis: a report from the EULAR Scleroderma Trials and Research Group Database, Ann Rheum Dis, 66, 754, 10.1136/ard.2006.062901 Reveille, 2001, Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic and immunogenetic determinants, Semin Arthritis Reum, 30, 332, 10.1053/sarh.2001.20268 Schlichthorst, 2016, Why do men go to the doctor? Sociodemographic and lifestyle factors associated with healthcare utilisation among a cohort of Australian men, BMC Public Health, 16, 1028, 10.1186/s12889-016-3706-5 Want, 2013, Do men consult less than women? An analysis of routinely collected UK general practice data, BMJ Open, 3, e003320, 10.1136/bmjopen-2013-003320 Mayes, 2003, Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population, Arthritis Rheum, 48, 2246, 10.1002/art.11073 Schmajuk, 2009, Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients, Clin Exp Rheumatol, 27, S22 Kuwana, 1994, Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis, Arthritis Rheum, 37, 75, 10.1002/art.1780370111 Stochmal, 2019, Antinuclear antibodies in systemic sclerosis: an update, Clin Rev Allergy Immunol, 58, 40, 10.1007/s12016-018-8718-8 Fraser, 2017, Data reveal state of Venezuela health system, Lancet, 389, 2095, 10.1016/S0140-6736(17)31435-6 Jordan, 2015, Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice, Rheumatology (Oxford), 54, 1454, 10.1093/rheumatology/keu530